| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.006 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.006 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.009 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.01 |